Company Filing History:
Years Active: 1991
Title: Shigemi Yoshida: Innovator in Physiologically Active Substances
Introduction
Shigemi Yoshida is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of new physiologically active substances. Her work has implications for various medical applications, showcasing her innovative spirit and dedication to research.
Latest Patents
Yoshida holds a patent for the discovery of two new physiologically active substances, named probestin and prostatin. These substances are produced from a newly identified microorganism, Streptomyces azureus MH663-2F6 strain, which is recognized as FERM P-9541 or FERM BP-1963. Probestin and prostatin exhibit inhibitory activity against aminopeptidase M and possess immunopotentiating properties, making them valuable in therapeutic contexts.
Career Highlights
Throughout her career, Shigemi Yoshida has been associated with Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai, where she has conducted extensive research. Her innovative work has led to advancements in the understanding of physiologically active substances and their potential applications in medicine.
Collaborations
Yoshida has collaborated with notable colleagues, including Tomio Takeuchi and Takaaki Aoyagi. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological solutions.
Conclusion
Shigemi Yoshida's contributions to the field of biotechnology through her innovative discoveries highlight her role as a leading inventor. Her work on probestin and prostatin exemplifies the potential of new substances in medical applications.